Sentence examples for a medium dose from inspiring English sources

The time they spent awake during the night was also less: 140 minutes on average for the placebo group, compared with 106 minutes for people who took a medium dose of tasimelteon.

The 1 mg/kg dose of rhTM is considered as a "medium" dose for rats [24].

In addition another 10% reduction of B diffusion can be obtained if a medium dose arsenic implant is preformed before F and B implantation.

An important factor in our study design was that a medium dose (50 100 U) of BTX-A was used, because this is within the most common dosing range in our clinical practice.

Conclusion: After high-dose inhaled corticosteroid, stepping down with the combination inhaler conferred further improvements in bronchoprotection, bronchodilatation, and clinical control, but not inflammatory markers, compared with that seen with a medium dose of inhaled corticosteroid.

Objective: We sought to evaluate step-down therapy with a fluticasone propionate-salmeterol (FP-SM) combination administered through a dry powder inhaler (DPI; Advair Diskus) versus a medium dose of hydrofluoroalkane 143a-beclomethasone dipropionate (HFA-BDP) administered through a breath-actuated pressurized metered-dose inhaler (QVAR Autohaler).

There are, however, systemic side-effects at high doses of ICS [ 8] and, in patients uncontrolled on a medium doses of ICS, addition of an inhaled long-acting β2-agonist (LABA) is the preferred therapy.

Those in the other groups were immunized with either a high-dose (TA), a medium-dose (TB), or a low-dose (TC) of the vaccine.

In order to examine if the tpx mutant is able to grow and persist in vivo, a medium-dose i.v. mouse infection model [34] was used in which the mice possess an immune response that restricts bacterial growth after two to three weeks of infection but fail to eliminate the bacilli.

The 60 rats were split into groups (each n = 6) between the two endpoints (days ten and 30) and the five treatment groups: 1) the scaffold group (empty defect and PCL-only scaffold); 2) CaSO4 group (PCL-only scaffold and CaSO4-only); 3) low dose (CaSO4-only and 0.01% A-79175); medium dose (CaSO4-only and 0.05% A-7915); and 5) high dose (CaSO4-only and 0.25% A-79175).

Before screening, patients had been taking ICS for ≥ 12 weeks, with a stable medium dose of ICS (FP 250 μg bid or equivalent) for ≥ 4 weeks.